| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 800 | 13.387 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 38.761 | 29.323 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.733 | 36.611 | 26.948 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -1.733 | 2.151 | 2.375 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -1.733 | 2.042 | 2.044 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Alexssia Biontech Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 10.659 | 8.004 |
| Current Assets | - | - | - | - | - | - | - | 28.849 | 3.553 | 5.481 |
| Inventories | - | - | - | - | - | - | - | 0 | 2.562 | 2.627 |
| Receivables | - | - | - | - | - | - | - | 0 | 12 | 1.139 |
| Cash | - | - | - | - | - | - | - | 28.849 | 979 | 1.715 |
| Shareholders Funds | - | - | - | - | - | - | - | -1.631 | 416 | 2.458 |
| Social Capital | - | - | - | - | - | - | - | 101 | 101 | 101 |
| Debts | - | - | - | - | - | - | - | 1.015 | 3.137 | 3.023 |
| Income in Advance | - | - | - | - | - | - | - | 29.465 | 10.659 | 8.004 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1083 - 1083" | |||||||||
| CAEN Financial Year |
1083
|
|||||||||
Comments - Alexssia Biontech Solutions S.r.l.